Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $791.36 billion, total revenue of $166.43 billion and a weighted average PE ratio of 52.98.
Market Cap
791.36B
Revenue
166.43B
Profits
14.94B
PE Ratio
52.98
Profit Margin
8.97%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 215.19B | -0.43% | 1,873,581 | 43.74B |
| 2 | DHR | Danaher Corporation | 159.81B | -0.39% | 3,179,579 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 57.02B | -0.47% | 386,582 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 41.18B | -1.91% | 2,142,040 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.46B | 0.41% | 1,689,929 | 15.90B |
| 6 | NTRA | Natera, Inc. | 33.75B | 1.03% | 1,369,753 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.90B | -0.56% | 103,902 | 3.94B |
| 8 | WAT | Waters Corporation | 23.50B | -0.39% | 468,793 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.42B | -1.18% | 679,324 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.30B | -0.91% | 738,192 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 19.71B | 0.73% | 799,603 | 4.29B |
| 12 | EXAS | Exact Sciences Corporation | 19.18B | -0.07% | 6,629,231 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.44B | 0.61% | 336,053 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 14.19B | 0.02% | 905,324 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.14B | -5.99% | 3,756,819 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.43B | -1.72% | 795,199 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 10.19B | -0.15% | 1,849,122 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.07B | 0.15% | 705,080 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.06B | -3.07% | 789,597 | 1.97B |
| 20 | BLLN | BillionToOne, Inc. | 5.07B | 7.33% | 167,946 | 209.03M |
| 21 | SHC | Sotera Health Company | 4.76B | 1.15% | 3,410,696 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 4.59B | -1.85% | 476,173 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.94B | -3.56% | 503,599 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.53B | -5.91% | 1,073,622 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.98B | -1.55% | 1,007,512 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.54B | -2.22% | 897,667 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.30B | 0.84% | 1,304,361 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.13B | -2.45% | 549,807 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.03B | -0.74% | 1,394,458 | 642.07M |
| 30 | CDNA | CareDx, Inc | 953.05M | -4.53% | 639,056 | 358.00M |
| 31 | FLGT | Fulgent Genetics, Inc. | 859.06M | -1.80% | 211,513 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 848.97M | -8.78% | 1,439,210 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 660.89M | -3.27% | 557,338 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 235.43M | 0.43% | 117,859 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 215.33M | -2.68% | 43,000 | 75.75M |
| 36 | MDXH | MDxHealth SA | 178.19M | -1.10% | 102,616 | 103.07M |
| 37 | XGN | Exagen Inc. | 163.17M | -3.87% | 149,771 | 63.60M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 150.20M | -6.09% | 26,935 | 4.40M |
| 39 | FONR | FONAR Corporation | 95.71M | -0.24% | 19,774 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 61.06M | -10.13% | 97,554 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 42.08M | -2.40% | 4,679 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 27.75M | -8.10% | 397,149 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 9.73M | -4.97% | 59,547 | - |
| 44 | ADVB | Advanced Biomed Inc. | 8.29M | 0.76% | 53,575 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.32M | -5.23% | 82,534 | 6.78M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.95M | 8.36% | 51,298 | - |
| 47 | MYNZ | Mainz Biomed N.V. | 6.28M | -0.85% | 101,090 | 659.94K |
| 48 | PRPH | ProPhase Labs, Inc. | 6.00M | -7.14% | 3,087,616 | 5.06M |
| 49 | ISPC | iSpecimen Inc. | 4.72M | -0.55% | 128,183 | 3.35M |
| 50 | XWEL | XWELL, Inc. | 4.56M | 1.79% | 10,228 | 29.52M |